235980 — Medpacto Share Price
0.000.00%
Last trade - 00:00- KR₩310bn
- KR₩244bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.37 | ||
| Price to Tang. Book | 4.39 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -48.61% | ||
| Return on Equity | -68.44% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 19th, 2013
- Public Since
- December 19th, 2019
- No. of Shareholders
- 37,865
- No. of Employees
- 61
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 33,580,695
- Address
- Borim Bldg., 92, Myeongdal-ro, Seocho-gu, SEOUL, 06668
- Web
- http://www.medpacto.com/
- Phone
- +82 269380200
- Auditors
- Shinhan Accounting Corporation
Upcoming Events for 235980
Q2 2024 MedPacto Inc Earnings Release
Similar to 235980
ABion
Korea Exchange - KOSDAQ
ABL Bio
Korea Exchange - KOSDAQ
ADM Korea
Korea Exchange - KOSDAQ
Amicogen
Korea Exchange - KOSDAQ
AprilBio Co
Korea Exchange - KOSDAQ
FAQ
What is the Medpacto share price?
As of Today at 19:14 UTC, shares in Medpacto are trading at KR₩9,220. This share price information is delayed by 15 minutes.
How has the Medpacto share price performed this year?
Shares in Medpacto last closed at KR₩9,220 and the price had moved by -56.07% over the past 365 days. In terms of relative price strength the Medpacto share price has underperformed the FTSE Developed Asia Pacific Index by -54.15% over the past year.
What are the analyst and broker recommendations for Medpacto?
The overall consensus recommendation for Medpacto is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Medpacto dividend yield?
Medpacto does not currently pay a dividend.
Does Medpacto pay a dividend?
Medpacto does not currently pay a dividend.
When does Medpacto next pay dividends?
Medpacto does not currently pay a dividend.
How do I buy Medpacto shares?
To buy shares in Medpacto you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medpacto?
As of the previous close price of KR₩9,220, shares in Medpacto had a market capitalisation of KR₩310bn.
Where are Medpacto shares listed?
Here are the trading details for Medpacto:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 235980
What kind of share is Medpacto?
Based on an overall assessment of its quality, value and momentum Medpacto is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medpacto share price forecast for 2024?
The analyst consensus target price for shares in Medpacto is KR₩23,000. That is 149.46% above the last closing price of KR₩9,220.
Analysts covering Medpacto currently have a consensus Earnings Per Share (EPS) forecast of -KR₩1,571 for the next financial year.
What is the trend in the Medpacto share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medpacto. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +14.73%.
As of the last closing price of KR₩9,220, shares in Medpacto were trading -12.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medpacto PE Ratio?
The Medpacto PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩9,220.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medpacto?
We do not have data on Medpacto's directors